: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :

"Finally, it has excellent bone conduction and osteoinduction capabilities, and bone regeneration can be completed within three to six months after implantation!"

Upon hearing this, everyone showed a shocked expression and stared at the content displayed on the screen in a daze.

Bone conduction and osteoinduction are the two most important mechanisms in the field of bone repair.

The former refers to the growth of bones from one side to the other, which is similar to the South-to-North Water Diversion.

Osteoinduction induces the body to grow bone cells in a non-bone environment, which is considered to be a creation of nothing.

Bone materials generally cannot meet these two items at the same time, and it is even more difficult to achieve the balance during the period. Either they are only in charge of conduction and growth, or they are inducing large quantities of osteocyte production in non-bone environments.

But Xu Qiu's rubber artificial bone actually found the balance point between the two mechanisms?!

...

Xu Qiu stopped telling, and the giant screen silently displays the details of the rubber artificial bones.

To everyone's surprise, this product did not use new materials, but used conventional materials of polylactic acid and hydroxyapatite to adjust the monomer ratio and molecular weight, and regulate the softness, plasticity, stability, etc. to a perfect point.

The old problem with hydroxyapatite materials is that after degradation, a large number of hydroxyl groups will be produced, resulting in an imbalance in the internal environment of acid and base.

In this regard, Xu Qiu also dispersed the fine hydroxyapatite particles evenly in the polylactic acid material through superdispersion technology, effectively neutralizing the acidic substances, and at the same time, achieving the sustained release of calcium ions during the degradation of hydroxyapatite, which makes the calcium ion concentration in the surrounding tissue fluid relatively balanced, which instead triggers osteogenesis efficiency!

Everyone was stunned.

What is the proportion of monomers and how much is the molecular weight adjusted?

There is also super-dispersed technology...how to operate it specifically?

They wanted to see all this very well, but these are the core secrets of the materials, so how could Xu Qiu give up someone?

"It turns out to be like this..."

"It's simply outrageous. He does scientific research and not only strives to solve old problems, but also provides great convenience to the final results!"

The contestants were dumbfounded and felt unbelievable.

Just as the degradation of hydroxyapatite materials leads to acid-base imbalance, the general idea is to solve the acid-base imbalance.

In fact, it is enough to control the hydroxyl content after degradation.

But Xu Qiu was not satisfied with this. While using super dispersion technology to solve the problem of acid and base imbalance, he also improved the sustained release of calcium ions during the degradation of hydroxyapatite, providing the best internal environment for osteogenesis...

This alone has surpassed the vast majority of people present.

...

"The final score is 96 points."

With Bemudong's announcement of exports, this achievement set a new record again and a new champion was born...

Immediately afterwards.

It is a new drug for multiple sclerosis.

The extremely rare disease, KJD, is easily misdiagnosed as multiple sclerosis. Xu Qiu has no idea about KJD, which has a 100% mortality rate, like rabies, but during the research process, he has also made a lot of research on multiple sclerosis.

This also allowed him to find a drug target.

This new drug targets CD20 positive B cells.

The drug can selectively bind to the target without affecting stem cells or plasma cells. After intravenous administration, it can exert neuroprotective function. The drug is used once every six months, which can not only delay the progress of multiple sclerosis, but also improve the compliance of multiple sclerosis.
Chapter completed!